Skip to main content

Biocryst Pharma Inc(BCRX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Biocryst Pharma Inc

4505 EMPEROR BOULEVARD SUITE 200
DURHAM NC 27703 USA
P: 919-859-1302
http://www.biocryst.com

Profile

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.

Key Executives

NameTitle
Charles K. GayerCEO/Director/President
Babar GhiasCFO/Chief Accounting Officer/Other Corporate Officer

More from The Globe